Isaac Zentner

Associate Director Process Development • Carisma Therapeutics

Isaac Zentner is the Associate Director of the Vector Group in the Process Development Department at Carisma Therapeutics. He is currently helping Carisma Therapeutics advance their mission of revolutionizing cancer treatments through their first-in-class first-in-human CAR-Macrophage cell therapy. Isaac received his PhD in Molecular and Cell Biology and Genetics from Drexel University College of Medicine. He utilizes his experience in drug discovery and infectious disease to develop and optimize clinical manufacturing of viral vectors, such as AAV and Adenovirus. He believes in keeping the goal of ‘improving patient outcomes’ as the primary motivator in all aspects of his biomedical research

Also Speaking

Aditi Singh

Global Senior Marketing Manager  • Sony Biotechnology Inc

Troels Jordansen

Chief Executive Officer • GlycoStem

Eric Hacherl

Vice President, Head of Manufacturing • Spark Therapeutics

Also Speaking


Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.


Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.